Over time, this leads to consistently higher drug levels, more side effects, and a pattern that can mimic overdosing
However, Novo Nordisk, Ozempics manufacturer, released results from two clinical trials in November 2025 that showed that taking an oral GLP-1 didnt slow disease progression among people with Alzheimers compared to those who took a placebo
When these receptors activate, they increase levels of neuropeptide Y and other satiety chemicals while simultaneously reducing hunger-driving hormones like ghrelin
I would probably not use the risk score calculator to determine if one of my patients should use or not use semaglutide, said Ali
It was better, of course, but not really exciting
But even standard doses can cause appetite loss and food aversions in some people